4
Changes in Ownership
BIOMARIN PHARMACEUTICAL INC Filed Acc 0001628280-26-019008
EVP, Chief Financial Officer gave up 9,945 shares (to pay taxes)
- EVP, Chief Financial Officer acquired 18,740 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Mueller Brian · EVP, Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-13 | Shares withheld for taxes : show line 1 in the form | −9,945 | $58.51 | $581,882 | 106,691 | D |
| 2026-03-16 | Grant or award : show line 2 in the form | +18,740 | 125,431 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-16 | Grant or award : show line 3 in the form Stock Option (Right to Buy Common Stock) | +44,600 | 44,600 | D |
Loading xslF345X05/wk-form4_1773794751.xml…